series-c-plus
Stage
2017
Founded
2
Investors
About
Pairwise develops and licenses a proprietary CRISPR-based gene editing platform to accelerate the breeding of climate-resilient, disease-resistant, and high-yield crops for global agricultural partners.
Explore Pairwise's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.